India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease - Reuters
India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOX1FncDFzSWFMZDR6aHBSZHRNd3hDX3BHRnVsNkF6V01Ud1BwWWhSMU9TREFneEFZd2Z6dlI1OUpEMkF1cmVLWjBvVS1lWkd2LU5aWVdSWFpUdkdOSlk4WW5IRm05ajBLUzlBdm9iWDZ6bjBLWWw0SHdCTTE2TU9GaXhrN0E4d1ZNRlNkVXNEV2NoMUttVzdhLS1EQlFDMXJackIwYm9FQ2V6c211RmwxT0NXTTJOS19GNXdPUmZzaWhTb0ZkbWx5MzBxRWx0VUp1blBBWjhRaw?oc=5" target="_blank">India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMNew weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
August 10, 2026 at 03:25 PMUltragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
August 19, 2026 at 10:36 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PM